The global nuclear medicine equipment market size was US$ 2.5 billion in 2021. The global nuclear medicine equipment market size is forecast to reach US$ 3.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.2% during the forecast period from 2022 to 2030.
Nuclear medicine is a discipline of medicine concerned with the use of radiotracers in disease therapy and diagnosis. Nuclear medicine equipment helps in the treatment of chronic disease, cardiovascular disease, and gastrointestinal cancer. In the study of metabolism, tissue blood flow, expression of cell receptors in normal and pathological cells, neurotransmitter activity, homing, cell trafficking, and apoptosis, nuclear medicine equipment such as imaging technologies are used.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global nuclear medicine equipment market. Several governments worldwide imposed several regulations in order to curb the spread of the deadly virus. This decreased traditional nuclear imaging procedures to electric surgery for cardiovascular disease and diagnosis of various types of cancers since hospitals and clinics had to focus on treating COVID-19 patients. Therefore, the decrease in nuclear imaging procedures led to a decline in the demand for a product like SPECT.
Regional Insights
North America garnered the major market share in 2021 and is forecast to remain dominant during the forecast period. As a result of the growing nuclear medicine in the U.S. due to various technical improvements. In addition, the increasing introduction of new radiopharmaceuticals for diagnostics and therapeutics fuel the market growth in the region.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the larger consumer base of Japan. The practice of nuclear medicine in Japan has advanced significantly in recent years, with a large increase in the frequency of hybrid SPECT/CT exams. Furthermore, the rising demand for Alzheimer's and Parkinson's disease treatment and diagnostics in China and India drives the market growth in the region.
Leading Competitors
The leading prominent companies profiled in the global nuclear medicine equipment market are:
Scope of the Report
The global nuclear medicine equipment market segmentation focuses on Product, Application, End-User, and Region.
Segmentation based on Product
Segmentation based on Application
Segmentation based on End-User
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)
5.3 POSITRON EMISSION TOMOGRAPHY (PET)
6 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 ONCOLOGY
6.3 NEUROLOGY
6.4 CARDIOLOGY
6.5 OTHER APPLICATIONS
7 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY END-USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 IMAGING CENTRES
7.4 ACADEMIC AND RESEARCH INSTITUTES
8 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 SIMEN HEALTHINEERS
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 FUJIFILM HOLDINGS
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 CANON INCORPORATED
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 DIGIRAD CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 MEDISO MEDICAL IMAGING SYSTEMS
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 SURGICEYE GMBH
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 GENERAL ELECTRIC COMPANY
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 KONINKLIJKE PHILIPS N.V.
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 BOZLU HOLDING
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 NUEROSOFT MEDICAL SYSTEMS
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved